Physicians

Director, Transfusion Services

Department / Division
Pathology / Pathology Clinical Services

Address
DUMC 2928
Durham, NC 27710

Office Telephone
919-681-4666

Fax Telephone
919-681-3081

Training

• MD, Wake Forest University School of Medicine (North Carolina), 1990

Residency

• Pathology, Duke University Medical Center, 1995

Fellowship

• Transfusion Medicine/Blood Bank, UNC Hospitals, 1996

Other Training

• Fellow, College of American Pathologists

Clinical Interests
Blood banking, transfusion medicine, apheresis (donor, therapeutic, cellular therapy), clinical consultation

Research Interests
Blood banking, transfusion medicine, apheresis(donor, therapeutic, cellular therapy), blood components, blood utilization

Industry Relationships and Collaborations (What's this?)

This faculty member has no reported relationships with industry.

Representative Publications
Stafford-Smith, M; Lockhart, E; Bandarenko, N; Welsby, I. Many, but not all, outcome studies support exclusion of female plasma from the blood supply. Expert Review of Hematology. 2010;3:551-558. (2010) Abstract

Szczepiorkowski, ZM; Winters, JL; Bandarenko, N; Kim, HC; Linenberger, ML; Marques, MB; Sarode, R; Schwartz, J; Weinstein, R; Shaz, BH; Apheresis Applications Committee of the American Society for Apheresis. Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. Journal of Clinical Apheresis. 2010;25:83-177. (2010) Abstract

Welsby, I; Crow, J; Bandarenko, N; Lappas, G; Phillips-Bute, B; Stafford-Smith, M. A clinical prediction tool to estimate the number of units of red blood cells needed in primary elective coronary artery bypass surgery. Transfusion. 2010;50:2337-2343. (2010) Abstract

Bennett-Guerrero, E; Stafford-Smith, M; Waweru, PM; Bredehoeft, SJ; Campbell, ML; Haley, NR; Phillips-Bute, B; Newman, MF; Bandarenko, N. A prospective, double-blind, randomized clinical feasibility trial of controlling the storage age of red blood cells for transfusion in cardiac surgical patients. Transfusion. 2009;49:1375-1383. (2009) Abstract

Zakarija, A; Kwaan, HC; Moake, JL; Bandarenko, N; Pandey, DK; McKoy, JM; Yarnold, PR; Raisch, DW; Winters, JL; Raife, TJ; Cursio, JF; Luu, TH; Richey, EA; Fisher, MJ; Ortel, TL; Tallman, MS; Zheng, XL; Matsumoto, M; Fujimura, Y; Bennett, CL. Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney International, Supplement. 2009;S20-S24. (2009) Abstract

Bandarenko, N; Cancelas, J; Snyder, EL; Hay, SN; Rugg, N; Corda, T; Joines, AD; Gormas, JF; Pratt, GP; Kowalsky, R; Rose, M; Rose, L; Foley, J; Popovsky, MA. Successful in vivo recovery and extended storage of additive solution (AS)-5 red blood cells after deglycerolization and resuspension in AS-3 for 15 days with an automated closed system. Transfusion. 2007;47:680-686. (2007) Abstract

Shaz, BH; Winters, JL; Bandarenko, N; Szczepiorkowski, ZM. How we approach an apheresis request for a Category III, Category IV, or noncategorized indication. Transfusion. 2007;47:1963-1971. (2007) Abstract

Afenyi-Annan, A; Bandarenko, N. Transfusion practices for patients with sickle cell disease at a major academic medical center. Immunohematology. 2006;22:103-107. (2006) Abstract

Hay, SN; Egan, JA; Millward, PA; Bandarenko, N; Brecher, ME. Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state. Therapeutic Apheresis and Dialysis. 2006;10:237-241. (2006) Abstract

Bandarenko, N; Brecher, ME. United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange. Journal of Clinical Apheresis. 1998;13:133-141. (1998) Abstract